AU2009905647A0 - Combination for treating metabolic disorders - Google Patents

Combination for treating metabolic disorders

Info

Publication number
AU2009905647A0
AU2009905647A0 AU2009905647A AU2009905647A AU2009905647A0 AU 2009905647 A0 AU2009905647 A0 AU 2009905647A0 AU 2009905647 A AU2009905647 A AU 2009905647A AU 2009905647 A AU2009905647 A AU 2009905647A AU 2009905647 A0 AU2009905647 A0 AU 2009905647A0
Authority
AU
Australia
Prior art keywords
combination
metabolic disorders
treating metabolic
treating
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009905647A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Original Assignee
University of Sydney
Filing date
Publication date
Application filed by University of Sydney filed Critical University of Sydney
Publication of AU2009905647A0 publication Critical patent/AU2009905647A0/en
Priority to PCT/AU2010/001545 priority Critical patent/WO2011060492A1/en
Abandoned legal-status Critical Current

Links

AU2009905647A 2009-11-18 2009-11-18 Combination for treating metabolic disorders Abandoned AU2009905647A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2010/001545 WO2011060492A1 (en) 2009-11-18 2010-11-18 Combination for treating metabolic disorders

Publications (1)

Publication Number Publication Date
AU2009905647A0 true AU2009905647A0 (en) 2009-12-03

Family

ID=

Similar Documents

Publication Publication Date Title
WO2010144865A9 (en) Methods for treating gastrointestinal disorders
EP2558115A4 (en) Methods for treating metabolic disorders using fgf
IL219914A (en) 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
IL197001A0 (en) Combination treatment for metabolic disorders
ZA201203342B (en) Treatments for gastrointestinal disorders
ZA201107449B (en) Compounds for the treatment of metabolic disorders
WO2011044264A9 (en) Pyrrolopyrazoles for treating cns disorders
EP2271358A4 (en) Neurodegenerative disorders
ZA201107446B (en) Compounds for the treatment of metabolic disorders
ZA201107445B (en) Compound for the treatment of metabolic disorders
PL2536742T3 (en) Treatments for gastrointestinal disorders
EP2557920A4 (en) Methods for treating glucose metabolic disorders
EP2240192A4 (en) Treatment for dermatological conditions
IL207906A0 (en) Treatment for ocular-related disorders
GB0822077D0 (en) Novel treatments
EP2240024A4 (en) Compounds for the treatment of metabolic disorders
AU2009905647A0 (en) Combination for treating metabolic disorders
GB0906010D0 (en) Acne treatment
GB0917199D0 (en) Metabolic disorders
GB0904289D0 (en) Compounds for the treatment of metabolic disorders
GB0904288D0 (en) Compounds for the treatment of metabolic disorders
GB0904286D0 (en) Compounds for the treatment of metabolic disorders
GB0904290D0 (en) Compounds for the treatment of metabolic disorders
AU2009903796A0 (en) Treatment
AU2008901036A0 (en) Combination therapy for cell disorders